Labcorp Launches Weight Loss Management Testing Solutions
BURLINGTON, N.C., March 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the introduction of its Weight Loss Management portfolio. The new offering features educational resources and convenient testing solutions, equipping individuals and their physicians with baseline and ongoing health indicators to inform treatment options, including lifestyle modifications, Glucagon-like peptide-1 (GLP-1) medications or bariatric surgery.
- GLP-1 medications for weight loss and diabetes management are also dramatically changing the weight management landscape.
- The Weight Management Tracking Test assesses average blood sugar and lipid levels to monitor metabolic health as an individual progresses along the weight loss journey.
- "The introduction of GLP-1s and other weight loss treatments has increased interest from individuals and their doctors seeking solutions for effective weight management.
- "Our Weight Loss Management offering simplifies the process of obtaining baseline measurements and tracking health progress to empower informed conversations about weight loss between individuals and their doctors."